Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutrafol (including the marketed product "Hair Nutra Growth") is a **physician-formulated, oral dietary supplement** designed to promote hair growth and improve hair quality in individuals with thinning hair. It is classified as a **nutraceutical** and targets multiple potential causes of hair loss, including inflammation, androgen (DHT) signaling, stress, oxidative damage, and nutritional insufficiency. The proprietary "Synergen Complex" contains bio-optimized phytoactive ingredients such as curcumin, ashwagandha, saw palmetto, tocotrienols, and piperine, as well as marine collagen peptides, amino acids, organic kelp, hyaluronic acid, vitamins, and minerals. The supplement is available in several formulations tailored to demographics and life stages. Multiple randomized, double-blind, placebo-controlled clinical trials suggest Nutrafol may increase the number of terminal and vellus hairs, improve volume, and reduce shedding in women and men with thinning hair. No significant adverse effects were observed in clinical studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nutrafol.